Final Program [International Conference on AIDS (14th: 2002: Barcelona, Spain)]

Poster Exhibitions Monday July 8

MoPeB3222 Prophylaxis with cotrimoxazole and isoniazid in
H IV-infected patients with smear-positive
tuberculosis: MOIPMA trial
EE Zilstra', M J Boeree', H T Banda', A D Harries',
D Sauvageot2, J Perriens3, B Samb3
(iMalawi; 2France; 3Switzerland)
MoPeB3223 Multidisciplinary local AIDS care teams enhance
comprehensive HIV/AIDS care in diverse
international settings
R G Marlink', J R Ayres2, S Gruskin', M Gonzalez
Rivera3, S Kapiga', U G Lalloo4, S M'Boups,
W Senaratana6, D Tarantola7 (United States;
2Brazil; 3Puerto Rico; 4South Africa; 5Senegal;
6Thailand; ZSwitzerland)
MoPeB3224 Unrecognised interactions between
antiretrovirals (ARV) and concomitant chronically
administered medication in a managed health
care program in Southern Africa
L Regensberg, S Andrews, G Maartens, C Pead,
S Nortier (South Africa)
MoPeB3225 The senegalese initiative on access to
antiretroviral therapy: current situation and
perspectives, how to translate pilot study results
to public health realities in a country with limited
resources
P55 Sow Papa Salif, N F G Ngom Gueye Nddye
Fatou, N D Diakhate Ndella, PM G Gueye Papa
Mandoumbe, N C T Toure Kane Ndeye Coumba, S
T Thiam Sophie, I L Lanidce Isabelle, B N Ndiaye
Bara, K D Diop Karim, S B Badiane Salif, OS Sylla
Omar, I N Ndoye Ibra, S M Mboup Souleymane
(Senegal)
MoPeB3226 Response to antiretroviral medications among
children with HIV at the Mildmay center, Uganda
V Moss', S Malamba', D Katuntu', H Barigye',
R Downing', F Banage', P Weidle2, J Mermin'
('Uganda; 2United States)
MoPeB3227 Cotrimoxazole adherence and toxicity among
persons with HIV in rural Uganda
j R Lule', J Mermin', S Malamba', A Coutinho',
F Kizito', D Nakanjako', B Waiswa', R Ransom',
R Quick2 ('Uganda; 2United States)
MoPeB3228 PR enhancing care initiative: participatory
research to enhance the care of people with
HIV/AIlDS
M Gonzdlez, A Bauermister (Puerto Rico)
MoPeB3229 High levels of observance reached in an African
cohort: the experience of Senegal
K Diop, I Laniece, M Ciss, A Desclaux, B Ndiaye,
/ Ndoye, K Sow (Senegal)
MoPeB323o Building capacity to provide HIV prevention and
treatment through education and consultation to
clinical providers and care systems
L Frank (United States)
MoPeB3231 Antiretroviral therapy in limited resource
countries: Example of Morocco
R Bensghir L Marih, M Sodqi, A Chakib,
H Himmich (Morocco)
MoPeB3232 Integrating voluntary counseling and testing
(VCT) in primary health care facilities
SSallet, C Sheard, R Hegner, H Hausler
(South Africa)
MoPeB3233 Establishment of a continuum of HIV/AIDS care
and enhancement of home-based care in
resource poor settings in KwaZulu-Natal, South
Africa
R A Pawinski, CC inabhai, U G Laloo, K Mtinjana
(South Africa)

MoPeB3234 A comprehensive HIV/AIDS training course to
meet the needs of public sector health care
workers in the province of KwaZulu Natal (KZN),
South Africa
U G Lalloo', R A Pawinski', R Bobat', D Moodley',
C C]inabhai', FAmod', S Conway', G Friedland2
(South Africa; 2United States)
MoPeB3235 The cost of care of HIV/AIDS patients among
health facilities in kwaZulu-Natal, South Africa
C C Jinabhai, R A Pawinski, I Wamukuo, U G Lalloo
(South Africa)
MoPeB3236 Efficacy and toxicity to cotrimoxazole prophylaxis
in HIV-1 infected Ugandan adults
C Watera, I Whitworth, J Nakiyingi, R Muwonge,
A Brink, G Miiro, L Antvelink (Uganda)
MoPeB3237 A review of the implementation of a voluntary
testing and counselling programme, using lay
counsellors and rapid HIV tests in KwaZulu Natal
South Africa
L Campbell (South Africa)
MoPeB3238 Most opportunistic infections can be managed at
primary health care level
F Louis, H Reuter, H Cuppens, D Coetzee,
N Ntwana, K Hilderbrand (South Africa)
MoPeB3239 Implementation of an antiretroviral (ART)
program in Yaounde, Cameroon
R Mougnutou', A Bourgeois, A Braye-Mitche//,
J Mbuagbaw', C Laurent, B Lactouock', L Ciaffi',
E Mpoudi Ngole', E Delaporte2 ('Cameroon;
2France)
MoPeB324o Peripheral neuropathy in HIV-1 adult infected
patients using Stavudine and Didanosine in a
combination therapy with Efavirenz
A Ndir', S Thiam', A Canestri', R Landman2
N F Gueye', N Diakhate', PM Gueye', L M Diouf,
N C Tourd Kane', B Ndiaye', I Laniece', PS Sow',
S Badiane', I Ndoye', S Mboup' (Senegal;
2France)
MoPeB3241 Recycling works! The collection and redistribution
of unused antiretrovirals - Aid for AIDS Latin
American Outreach Program, 2001 - 2002
j Aguais', T Horn', D Ramirez', TAguais2,
M Castaneda3, CAlain4, M Lavander5as
('United States; 2Venezuela; 3Peru; 4Chile;
5Dominican Republic)
MoPeB3242 Antiretroviral therapy in South African children
with access to managed care
M Cotton MS Hislop, L Regensberg
(South Africa)
MoPeB3243 A compact, affordable and portable CD4 T-cell
machine
F Mandy', A Bese', P Barnabe', Z Solajic',
M Bergeron', GJanossy2
(Canada; 2United Kingdom)
MoPeB3244 The MTCT Plus Program: a major initiative to
provide care and treatment to HIV-infected
women and their children
A Rosenfield, W E/-Sadr, M Rabkin, S Hammer,
E Abrams, L Kuhn, P Collins, D Hoos, L Myer,
A Berkman (United States)
MoPeB3245 Impact of increasing access to HIV/TB care and
prevention in a resource-poor district: lessons
from the Malawi ProTEST Project
NJ Hargreaves R B K Chimzizi', A D Harries
P Godfrey-Faussett2, 0 Mughogho',
FM Salaniponi' ('Malawi; 2United Kingdom)

Monday

XIV International AIDS Conference BARCELONA - JULY 7-12

39